Relationship between polycystic ovary syndrome and high periostin level
| dc.authorid | 0000-0002-9959-9433 | |
| dc.contributor.author | Eroglu, Semra | |
| dc.contributor.author | Cakmakliogullari, Elcin Kal | |
| dc.date.accessioned | 2026-01-24T12:29:17Z | |
| dc.date.available | 2026-01-24T12:29:17Z | |
| dc.date.issued | 2024 | |
| dc.department | Alanya Alaaddin Keykubat Üniversitesi | |
| dc.description.abstract | OBJECTIVE: There is growing evidence suggesting a relationship between periostin levels, inflammation, and ovarian dysfunction. In this prospective case-control study, we aimed to investigate serum periostin levels and their relationship with metabolic parameters in patients with polycystic ovary syndrome. METHODS: We conducted a prospective case-control study involving 45 polycystic ovary syndrome patients and 45 control subjects, matched in a 1:1 ratio. Serum samples collected from both study and control groups were analyzed using enzyme-linked immunosorbent assay. RESULTS: The demographic characteristics were similar between the polycystic ovary syndrome and control groups (p>0.05). Periostin levels were significantly higher in patients with polycystic ovary syndrome compared with the control group (4.67 +/- 2.46 vs. 2.60 +/- 1.41 ng/mL, respectively; p=0.000). CONCLUSION: Our study revealed a significant elevation in periostin levels among polycystic ovary syndrome patients compared with controls. These findings suggest that periostin could serve as a potential marker for assessing disease severity in polycystic ovary syndrome patients. | |
| dc.description.sponsorship | Karabuk University [17-KP-348] | |
| dc.description.sponsorship | Acknowledgments This work was supported by Karabuk University under Grant number 17-KP-348. | |
| dc.identifier.doi | 10.1590/1806-9282.20240138 | |
| dc.identifier.issn | 0104-4230 | |
| dc.identifier.issn | 1806-9282 | |
| dc.identifier.issue | 6 | |
| dc.identifier.pmid | 39045965 | |
| dc.identifier.scopus | 2-s2.0-85199376165 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.uri | https://doi.org/10.1590/1806-9282.20240138 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12868/5238 | |
| dc.identifier.volume | 70 | |
| dc.identifier.wos | WOS:001276106600001 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Assoc Medica Brasileira | |
| dc.relation.ispartof | Revista Da Associacao Medica Brasileira | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20260121 | |
| dc.subject | Polycystic ovary syndrome | |
| dc.subject | Periostin | |
| dc.subject | Inflammation | |
| dc.subject | Insulin resistance | |
| dc.title | Relationship between polycystic ovary syndrome and high periostin level | |
| dc.type | Article |












